211 related articles for article (PubMed ID: 29298863)
1. Dual regulation of HMGB1 by combined JNK1/2-ATF2 axis with miR-200 family in nonalcoholic steatohepatitis in mice.
Chen X; Ling Y; Wei Y; Tang J; Ren Y; Zhang B; Jiang F; Li H; Wang R; Wen W; Lv G; Wu M; Chen L; Li L; Wang H
FASEB J; 2018 May; 32(5):2722-2734. PubMed ID: 29298863
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent.
Gan LT; Van Rooyen DM; Koina ME; McCuskey RS; Teoh NC; Farrell GC
J Hepatol; 2014 Dec; 61(6):1376-84. PubMed ID: 25064435
[TBL] [Abstract][Full Text] [Related]
3. FBXW7 suppresses HMGB1-mediated innate immune signaling to attenuate hepatic inflammation and insulin resistance in a mouse model of nonalcoholic fatty liver disease.
Zhang C; Chen F; Feng L; Shan Q; Zheng GH; Wang YJ; Lu J; Fan SH; Sun CH; Wu DM; Li MQ; Hu B; Wang QQ; Zhang ZF; Zheng YL
Mol Med; 2019 Jun; 25(1):29. PubMed ID: 31215394
[TBL] [Abstract][Full Text] [Related]
4. Palmitic acid induces autophagy in hepatocytes via JNK2 activation.
Tu QQ; Zheng RY; Li J; Hu L; Chang YX; Li L; Li MH; Wang RY; Huang DD; Wu MC; Hu HP; Chen L; Wang HY
Acta Pharmacol Sin; 2014 Apr; 35(4):504-12. PubMed ID: 24608675
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
Hur W; Lee JH; Kim SW; Kim JH; Bae SH; Kim M; Hwang D; Kim YS; Park T; Um SJ; Song BJ; Yoon SK
Int J Biochem Cell Biol; 2015 Jul; 64():265-76. PubMed ID: 25957914
[TBL] [Abstract][Full Text] [Related]
6. c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice.
Kodama Y; Kisseleva T; Iwaisako K; Miura K; Taura K; De Minicis S; Osterreicher CH; Schnabl B; Seki E; Brenner DA
Gastroenterology; 2009 Oct; 137(4):1467-1477.e5. PubMed ID: 19549522
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-29a Suppresses CD36 to Ameliorate High Fat Diet-Induced Steatohepatitis and Liver Fibrosis in Mice.
Lin HY; Wang FS; Yang YL; Huang YH
Cells; 2019 Oct; 8(10):. PubMed ID: 31652636
[TBL] [Abstract][Full Text] [Related]
8. MiR-150 deficiency ameliorated hepatosteatosis and insulin resistance in nonalcoholic fatty liver disease via targeting CASP8 and FADD-like apoptosis regulator.
Zhuge B; Li G
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):687-692. PubMed ID: 29107687
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease.
Zeng W; Shan W; Gao L; Gao D; Hu Y; Wang G; Zhang N; Li Z; Tian X; Xu W; Peng J; Ma X; Yao J
Sci Rep; 2015 Nov; 5():16013. PubMed ID: 26525891
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance.
Singh R; Wang Y; Xiang Y; Tanaka KE; Gaarde WA; Czaja MJ
Hepatology; 2009 Jan; 49(1):87-96. PubMed ID: 19053047
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-194 inhibition improves dietary-induced non-alcoholic fatty liver disease in mice through targeting on FXR.
Nie H; Song C; Wang D; Cui S; Ren T; Cao Z; Liu Q; Chen Z; Chen X; Zhou Y
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3087-3094. PubMed ID: 28951211
[TBL] [Abstract][Full Text] [Related]
12. JNK1 but not JNK2 promotes the development of steatohepatitis in mice.
Schattenberg JM; Singh R; Wang Y; Lefkowitch JH; Rigoli RM; Scherer PE; Czaja MJ
Hepatology; 2006 Jan; 43(1):163-72. PubMed ID: 16374858
[TBL] [Abstract][Full Text] [Related]
13. Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications.
Di Mauro S; Ragusa M; Urbano F; Filippello A; Di Pino A; Scamporrino A; Pulvirenti A; Ferro A; Rabuazzo AM; Purrello M; Purrello F; Piro S
Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1129-1139. PubMed ID: 27756518
[TBL] [Abstract][Full Text] [Related]
14. A negative feedback loop between microRNA-378 and Nrf1 promotes the development of hepatosteatosis in mice treated with a high fat diet.
Zhang T; Zhao X; Steer CJ; Yan G; Song G
Metabolism; 2018 Aug; 85():183-191. PubMed ID: 29625129
[TBL] [Abstract][Full Text] [Related]
15. HMGB1-RAGE pathway drives peroxynitrite signaling-induced IBD-like inflammation in murine nonalcoholic fatty liver disease.
Chandrashekaran V; Seth RK; Dattaroy D; Alhasson F; Ziolenka J; Carson J; Berger FG; Kalyanaraman B; Diehl AM; Chatterjee S
Redox Biol; 2017 Oct; 13():8-19. PubMed ID: 28551086
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice.
Li L; Chen L; Hu L; Liu Y; Sun HY; Tang J; Hou YJ; Chang YX; Tu QQ; Feng GS; Shen F; Wu MC; Wang HY
Hepatology; 2011 Nov; 54(5):1620-30. PubMed ID: 21809356
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-17A exacerbates high-fat diet-induced hepatic steatosis by inhibiting fatty acid β-oxidation.
Shen T; Chen X; Li Y; Tang X; Jiang X; Yu C; Zheng Y; Guo H; Ling W
Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1510-1518. PubMed ID: 28153707
[TBL] [Abstract][Full Text] [Related]
18. Dietary Saturated Fat Promotes Development of Hepatic Inflammation Through Toll-Like Receptor 4 in Mice.
Sutter AG; Palanisamy AP; Lench JH; Esckilsen S; Geng T; Lewin DN; Cowart LA; Chavin KD
J Cell Biochem; 2016 Jul; 117(7):1613-21. PubMed ID: 26600310
[TBL] [Abstract][Full Text] [Related]
19. MiR-146b attenuates high-fat diet-induced non-alcoholic steatohepatitis in mice.
Jiang W; Liu J; Dai Y; Zhou N; Ji C; Li X
J Gastroenterol Hepatol; 2015 May; 30(5):933-43. PubMed ID: 25559563
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of miR-144 elicits proinflammatory cytokine production by targeting toll-like receptor 2 in nonalcoholic steatohepatitis of high-fat-diet-induced metabolic syndrome E3 rats.
Li D; Wang X; Lan X; Li Y; Liu L; Yi J; Li J; Sun Q; Wang Y; Li H; Zhong N; Holmdahl R; Lu S
Mol Cell Endocrinol; 2015 Feb; 402():1-12. PubMed ID: 25534427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
